IRIS
VITA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.845
EU - Europa 30.547
AS - Asia 16.515
SA - Sud America 6.143
Continente sconosciuto - Info sul continente non disponibili 997
AF - Africa 463
OC - Oceania 24
AN - Antartide 1
Totale 87.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.065
RU - Federazione Russa 14.965
SG - Singapore 7.232
BR - Brasile 5.252
CN - Cina 4.690
IE - Irlanda 3.934
SE - Svezia 2.903
IT - Italia 1.909
HK - Hong Kong 1.618
DE - Germania 1.550
UA - Ucraina 1.243
FR - Francia 1.067
VN - Vietnam 947
FI - Finlandia 885
PL - Polonia 832
GB - Regno Unito 612
IN - India 528
CA - Canada 323
AR - Argentina 293
BD - Bangladesh 265
MX - Messico 190
TR - Turchia 169
EC - Ecuador 165
IQ - Iraq 149
ZA - Sudafrica 123
CO - Colombia 120
BE - Belgio 116
ID - Indonesia 112
PK - Pakistan 104
NL - Olanda 102
AT - Austria 99
VE - Venezuela 98
MA - Marocco 93
UZ - Uzbekistan 90
ES - Italia 77
JP - Giappone 76
CI - Costa d'Avorio 58
CL - Cile 58
PY - Paraguay 54
CR - Costa Rica 47
AZ - Azerbaigian 46
PE - Perù 46
JM - Giamaica 44
KE - Kenya 44
CZ - Repubblica Ceca 42
TN - Tunisia 40
SA - Arabia Saudita 39
LT - Lituania 38
NP - Nepal 36
IR - Iran 35
PH - Filippine 35
HN - Honduras 34
AE - Emirati Arabi Uniti 33
JO - Giordania 33
KZ - Kazakistan 31
IL - Israele 30
MY - Malesia 30
UY - Uruguay 28
EG - Egitto 27
DO - Repubblica Dominicana 26
BO - Bolivia 23
KG - Kirghizistan 23
AL - Albania 22
DZ - Algeria 22
OM - Oman 22
TH - Thailandia 22
NI - Nicaragua 21
EU - Europa 20
RS - Serbia 19
CH - Svizzera 18
LB - Libano 18
PA - Panama 17
RO - Romania 17
GT - Guatemala 16
AU - Australia 15
PS - Palestinian Territory 15
TT - Trinidad e Tobago 14
KR - Corea 11
PT - Portogallo 11
KW - Kuwait 10
PR - Porto Rico 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
GE - Georgia 9
SV - El Salvador 9
DK - Danimarca 8
EE - Estonia 8
AO - Angola 7
BA - Bosnia-Erzegovina 7
ET - Etiopia 7
GA - Gabon 7
HU - Ungheria 7
LK - Sri Lanka 7
MD - Moldavia 7
MN - Mongolia 7
NZ - Nuova Zelanda 7
QA - Qatar 7
SY - Repubblica araba siriana 7
BB - Barbados 6
BY - Bielorussia 6
Totale 86.439
Salva come PNG Salva come JPEG
Città #
Moscow 4.726
Ashburn 4.089
Dublin 3.928
Singapore 3.432
Dallas 3.091
Chandler 2.700
Jacksonville 2.573
Nyköping 1.764
San Jose 1.744
Beijing 1.689
Hong Kong 1.601
Council Bluffs 1.233
The Dalles 896
Warsaw 806
Princeton 743
Medford 644
Lauterbourg 632
Los Angeles 630
Cambridge 623
Des Moines 511
Dearborn 487
Ann Arbor 480
Munich 401
Messina 383
São Paulo 383
New York 356
Buffalo 338
Ho Chi Minh City 333
Boardman 313
Tianjin 211
Wilmington 204
Hanoi 185
Santa Clara 176
San Mateo 173
Shenyang 172
Rio de Janeiro 168
Jinan 167
Guangzhou 155
Orem 155
Woodbridge 149
Turku 145
Phoenix 141
Redondo Beach 134
Houston 133
Hyderabad 131
Atlanta 128
Belo Horizonte 128
Bremen 126
Frankfurt am Main 126
Helsinki 124
Nanjing 122
Lancaster 119
Rome 117
Pune 103
Brooklyn 102
Brussels 101
Brasília 95
Hebei 94
Seattle 93
Curitiba 91
Chicago 89
Milan 87
Ningbo 86
Shanghai 86
Zhengzhou 82
Chennai 81
Montreal 81
Tashkent 79
Hangzhou 73
Porto Alegre 72
San Francisco 70
Taizhou 70
Tokyo 70
Denver 68
Columbus 67
Baghdad 65
Haikou 65
London 65
Toronto 62
Campinas 61
Vienna 61
Guayaquil 60
Abidjan 58
Johannesburg 54
Nuremberg 52
Quito 52
Guarulhos 51
Dong Ket 49
Shenzhen 49
Norwalk 48
Ribeirão Preto 47
Salvador 47
Baku 46
Stockholm 46
Mexico City 44
Poplar 44
Amsterdam 43
Boston 43
Dhaka 43
Mumbai 42
Totale 48.255
Salva come PNG Salva come JPEG
Nome #
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 735
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 374
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 352
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 343
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 342
A COMPUTER-ASSISTED AUTOMATIC METHOD FOR MYELINATED NERVE-FIBER MORPHOMETRY 302
A checklist for clinical trials in rare disease: Obstacles and anticipatory actions-lessons learned from the FOR-DMD trial 299
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 295
90th ENMC International Workshop: European Spinal Muscular Atrophy Randomised Trial (EuroSMART) 9-10 February 2001, Naarden, The Netherlands 284
A histochemical study of fibre types in rat extraocular muscles 266
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 264
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 263
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 261
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 256
Clinical and pathological features of focal myositis 255
A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals 253
24-Holter ECG in type II and III SMA 252
Agenesis of the Internal Carotid Artery Associated with Generalized Epilepsy 251
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 250
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 243
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 239
A Nouvel serum MicroRNA signature to screen ATTR 237
Adolescenti e infezioni sessualmente trasmesse: conoscenze e comportamenti. 235
Behaviour of vinculin and talin in perineurial cells in healthy subjects and in subjects affected by diabteic neuropathy 233
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 227
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 226
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 226
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 226
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial 223
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 223
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 221
BILATERAL PARAMEDIAN THALAMIC INFARCT AFTER OCCLUSION OF THE ARTERY OF PERCHERON. 220
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 220
A cytochemical study of apoptosis in metabolic myopathies 216
Awareness and behavioural and psychological symptoms of dementia (BPSD) impact in Alzheimer's disease 213
A life threatening case of β-enolase deficiency 211
Disturbi acuti della visione 210
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 209
A CLSM study of dystrophin associated proteins and some extra-cellular matrix components in human skeletal muscle 207
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 207
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 207
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 207
A comparative analysis of somatic and autonomic neuropathy in chronic alcoholics. 206
Nusinersen versus sham control in later-onset spinal muscular atrophy 206
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 204
A decreased muscle content of HPRG correlates with the reduction of AMP deaminase activity observed in patients affected by myoadenylate deficiencies 203
Dolori muscolari, deficit di forza e/o disturbi sensitivi 203
Alexithymia, burden and resilience in ALS’ caregivers 203
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 201
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 201
alpha7/beta1 integrin distribution in correlation with talin-vinculin system 200
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 199
Effect of exercise on telomere length and telomere proteins expression in mdx mice 198
Hippo signaling pathway is altered in Duchenne muscular dystrophy 197
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 196
Autonomic nervous system involvement in spinal muscular atrophy. 194
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism. 193
Emergenze respiratorie nelle malattie neurologiche 193
[Neuromuscular block induced by fazadinium. Electrophysiological study on fast and slow muscles in the rabbit]. 192
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 192
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 191
Alterazioni neuropsicologiche in emodializzati: confronto tra adulti e anziani 191
Sleep and sleep‐modifying factors in chronic migraine patients during the COVID‐19 lockdown 190
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 190
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 189
An observational study of functional abilities in infants, children, and adults with type 1 SMA 189
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 188
Central and peripheral autonomic failure in cold induced sweating syndrome type 1 187
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 187
Clinical and genotypic of narcoleptic from North eastern Sicily: our sleep centre experience 186
Fahr's syndrome: local inflammatory factors in the pathogenesis of calcification 186
A benign case of congenital myotonic dystrophy 186
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 183
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 182
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 181
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 180
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 179
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 178
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron 177
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 177
Pilot study of serial casting in muscular dystrophy patients. 177
Adult-onset centronuclear myopathy: evidence against a neurogenic pathology. 176
Cardiovascular autonomic control in Becker muscular dystrophy 176
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 176
Pilot study of flavocoxid in ambulant DMD patients. 176
Pilot study of serial casting of ankles in muscular dystrophy patients. 176
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 175
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 175
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 174
A quantitative analysis of fibers in the controlateral sciatic nerves of the rabbit 174
Analisi comparativa della patologia vegetativa autonomica in emodializzati giovani e anziani 174
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 174
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 174
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 173
Apoptosis and apoptosis-related proteins in thyroid myopathies 173
A novel Cx32 mutation with unusual phenotype. 173
Autoimmune juvenile limb-girdle myasthenia 173
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis 173
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 173
Acute ischemic stroke due to endocarditis from Brucella infection 172
Totale 21.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 302.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 302.147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.527 0 0 0 201 275 35 324 199 94 323 521 1.555
2022/202310.860 931 917 491 761 888 1.013 123 607 4.721 40 281 87
2023/20242.590 215 393 195 198 223 545 72 161 29 196 49 314
2024/202513.121 200 135 212 743 549 361 300 2.888 3.298 713 1.383 2.339
2025/202636.666 1.612 2.763 3.084 2.833 2.820 7.992 4.485 4.203 4.249 1.443 650 532
2026/20277.480 1.117 2.917 1.613 1.833 0 0 0 0 0 0 0 0
Totale 87.535